# Haleon plc: overview HLN · NYSE · CIK 1900304 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/hln.md) · [Financials](/companies/hln/financials.md) · [Filings](/companies/hln/filings.md) · [Insiders](/companies/hln/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [9.5](/filings/0001558370-24-003331.md) | [10.9](/filings/0001558370-25-003368.md) | [11.3](/filings/0001104659-26-027443.md) | [11.2](/filings/0001104659-26-027443.md) | [11.0](/filings/0001104659-26-027443.md) | | Gross margin | % | [62.3%](/filings/0001558370-24-003331.md) | [60.6%](/filings/0001558370-25-003368.md) | [59.7%](/filings/0001104659-26-027443.md) | [60.7%](/filings/0001104659-26-027443.md) | [64.2%](/filings/0001104659-26-027443.md) | | Operating margin | % | [17.2%](/filings/0001558370-24-003331.md) | [16.8%](/filings/0001558370-25-003368.md) | [17.7%](/filings/0001104659-26-027443.md) | [19.6%](/filings/0001104659-26-027443.md) | [21.9%](/filings/0001104659-26-027443.md) | | Net margin | % | [14.6%](/filings/0001558370-24-003331.md) | [9.8%](/filings/0001558370-25-003368.md) | [9.3%](/filings/0001104659-26-027443.md) | [12.8%](/filings/0001104659-26-027443.md) | [15.1%](/filings/0001104659-26-027443.md) | | Diluted EPS | $ per share | [0.15](/filings/0001558370-24-003331.md) | [0.12](/filings/0001558370-25-003368.md) | [0.11](/filings/0001104659-26-027443.md) | [0.16](/filings/0001104659-26-027443.md) | [0.18](/filings/0001104659-26-027443.md) | | Free cash flow | $bn | [1.1](/filings/0001558370-24-003331.md) | [1.8](/filings/0001558370-25-003368.md) | [1.9](/filings/0001104659-26-027443.md) | [2.1](/filings/0001104659-26-027443.md) | [2.3](/filings/0001104659-26-027443.md) | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:Revenue. - Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hln/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $1.40bn | 149,934,507 | | Added +3,394,844 | | [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.13bn | 120,991,250 | | Added +7,022,091 | | [Clearbridge Investments, LLC](/funds/1348883.md) | 2026-06-30 | $301.8m | 32,342,126 | | Added +623,401 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $181.6m | 19,461,762 | | Added +295,509 | | [HARRIS ASSOCIATES L P](/funds/813917.md) | 2026-06-30 | $157.1m | 16,833,252 | | Added +1,801,211 | | [Harding Loevner LP](/funds/928196.md) | 2026-06-30 | $147.8m | 15,414,796 | | Reduced −297,754 | | [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $143.1m | 15,332,859 | | Added +6,633,766 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $132.3m | 14,181,817 | | Reduced −492,701 | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $101.2m | 10,850,097 | | Reduced −84,131 | | [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $101.0m | 10,824,395 | | Added +2,544,927 | ## Recent filings [All 499 filings](/companies/hln/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-29 | 06:46 ET | [6-K](/filings/0001654954-26-009194.md) | Report of a foreign private issuer, period 2026-10-29 | 0001654954-26-009194 | | 2026-10-01 | 06:16 ET | [6-K](/filings/0001654954-26-008695.md) | Report of a foreign private issuer, period 2026-10-01 | 0001654954-26-008695 | | 2026-09-24 | 07:44 ET | [6-K](/filings/0001654954-26-008547.md) | Report of a foreign private issuer, period 2026-09-24 | 0001654954-26-008547 | | 2026-09-18 | 07:46 ET | [6-K](/filings/0001654954-26-008440.md) | Report of a foreign private issuer, period 2026-09-18 | 0001654954-26-008440 | | 2026-09-01 | 07:51 ET | [6-K](/filings/0001654954-26-008000.md) | Report of a foreign private issuer, period 2026-09-01 | 0001654954-26-008000 | | 2026-08-21 | 13:18 ET | [6-K](/filings/0001104659-26-099613.md) | Report of a foreign private issuer, period 2026-08-21 | 0001104659-26-099613 | | 2026-08-19 | 08:22 ET | [6-K](/filings/0001654954-26-007739.md) | Report of a foreign private issuer, period 2026-08-19 | 0001654954-26-007739 | | 2026-08-19 | 06:12 ET | [6-K](/filings/0001654954-26-007733.md) | Report of a foreign private issuer, period 2026-08-19 | 0001654954-26-007733 | | 2026-08-17 | 06:48 ET | [6-K](/filings/0001654954-26-007675.md) | Report of a foreign private issuer, period 2026-08-17 | 0001654954-26-007675 | | 2026-08-13 | 06:35 ET | [6-K](/filings/0001654954-26-007546.md) | Report of a foreign private issuer, period 2026-08-13 | 0001654954-26-007546 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-027443.md), filed Mar 13, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1900304 - Tickers: HLN, HLNCF - Exchange: NYSE - SIC code: 2844 Perfumes, Cosmetics & Other Toilet Preparations - State of incorporation: X0 - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 07:34 ET. No prices; not investment advice.